{"transactions":[{"id":730551,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:19.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":88424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":135981,"source":{"system":"sec-edgar","filing":"0001601830-26-000085","document":"wk-form4_1782160336.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805339/000160183026000085/wk-form4_1782160336.xml","form_type":"4"}},{"id":912683,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:18.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":10.18,"underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001805339-26-000002","document":"form4-02102026_040207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000180533926000002/form4-02102026_040207.xml","form_type":"4"}},{"id":912682,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:18.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":11.85,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001805339-26-000002","document":"form4-02102026_040207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000180533926000002/form4-02102026_040207.xml","form_type":"4"}},{"id":912681,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:18.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":11.2,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001805339-26-000002","document":"form4-02102026_040207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000180533926000002/form4-02102026_040207.xml","form_type":"4"}},{"id":912680,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:18.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":11.68,"underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001805339-26-000002","document":"form4-02102026_040207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000180533926000002/form4-02102026_040207.xml","form_type":"4"}},{"id":912679,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:18.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":13.33,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001805339-26-000002","document":"form4-02102026_040207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000180533926000002/form4-02102026_040207.xml","form_type":"4"}},{"id":912678,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock - Restricted Stock Units","published_at":"2026-02-10T16:15:18.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":29865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each restricted stock unit (\"RSU\") award that was outstanding as of immediately prior to the Effective Time held by the Reporting Person, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001805339-26-000002","document":"form4-02102026_040207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000180533926000002/form4-02102026_040207.xml","form_type":"4"}},{"id":1103883,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T21:22:36.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":22016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest and become exercisable on the earlier of June 18, 2026 or the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":22016,"derivative":{"exercise_price":5.11,"expiration_date":"2035-06-18","underlying":"Class A Common Stock","underlying_shares":22016},"source":{"system":"sec-edgar","filing":"0001601830-25-000106","document":"wk-form4_1750713747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805339/000160183025000106/wk-form4_1750713747.xml","form_type":"4"}},{"id":1103882,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-23T21:22:36.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":11008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 18, 2026 or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":47557,"source":{"system":"sec-edgar","filing":"0001601830-25-000106","document":"wk-form4_1750713747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805339/000160183025000106/wk-form4_1750713747.xml","form_type":"4"}},{"id":1112259,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T17:44:37.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date."}],"balance_after":28500,"derivative":{"exercise_price":10.18,"expiration_date":"2032-06-10","underlying":"Commont Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001029142-25-000095","document":"wk-form4_1749851072.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000102914225000095/wk-form4_1749851072.xml","form_type":"4"}},{"id":1112258,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T17:44:37.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":5758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company."}],"balance_after":29865,"source":{"system":"sec-edgar","filing":"0001029142-25-000095","document":"wk-form4_1749851072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000102914225000095/wk-form4_1749851072.xml","form_type":"4"}},{"id":1197192,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-19T20:27:16.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":73099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a grant of options automatically granted pursuant to Recursion's Outside Director Compensation Policy. The shares subject to this option will vest and become exercisable as to 1/3rd of the shares subject to the award on the first three anniversaries of March 17, 2025, subject to the Reporting Person continuing to be a service provider through the applicable vesting dates."}],"balance_after":73099,"derivative":{"exercise_price":6.84,"expiration_date":"2035-03-17","underlying":"Class A Common Stock","underlying_shares":73099},"source":{"system":"sec-edgar","filing":"0001601830-25-000047","document":"wk-form4_1742416029.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805339/000160183025000047/wk-form4_1742416029.xml","form_type":"4"}},{"id":1197191,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-19T20:27:16.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":36549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to Recursion's Outside Director Compensation Policy. The restricted stock units will vest as to 1/3rd of the shares subject to the award on the first three anniversaries of March 17, 2025, subject to the Reporting Person continuing to be a service provider through the applicable vesting dates."}],"balance_after":36549,"source":{"system":"sec-edgar","filing":"0001601830-25-000047","document":"wk-form4_1742416029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805339/000160183025000047/wk-form4_1742416029.xml","form_type":"4"}},{"id":1500881,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-28T20:19:28.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date."}],"balance_after":22500,"derivative":{"exercise_price":11.85,"expiration_date":"2031-05-22","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-24-065573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024065573/ownership.xml","form_type":"4"}},{"id":1500880,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-28T20:19:28.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":5357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company."}],"balance_after":24107,"source":{"system":"sec-edgar","filing":"0000950170-24-065573","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024065573/ownership.xml","form_type":"4"}},{"id":1873680,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-31T17:34:51.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date."}],"balance_after":22500,"derivative":{"exercise_price":11.2,"expiration_date":"2030-05-25","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-23-033176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919123033176/doc4.xml","form_type":"4"}},{"id":1873679,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T17:34:51.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":5357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company. The reporting person has reported prior awards of restricted stock units in Table II on Form 4. The total reported in Column 5 includes 5,357 newly awarded restricted stock units and 13,393 restricted stock units previously reported in Table II."}],"balance_after":18750,"source":{"system":"sec-edgar","filing":"0001209191-23-033176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919123033176/doc4.xml","form_type":"4"}},{"id":2254041,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T17:01:59.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":11250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date."}],"balance_after":11250,"derivative":{"exercise_price":11.68,"expiration_date":"2029-05-25","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001209191-22-032619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919122032619/doc4.xml","form_type":"4"}},{"id":2254040,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-27T17:01:59.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":2679,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred until the Reporting Person no longer provides services to the Company."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred until the Reporting Person no longer provides services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred until the Reporting Person no longer provides services to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred until the Reporting Person no longer provides services to the Company."}],"balance_after":2679,"derivative":{"underlying":"Common Stock","underlying_shares":2679},"source":{"system":"sec-edgar","filing":"0001209191-22-032619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919122032619/doc4.xml","form_type":"4"}},{"id":2474027,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-14T19:23:31.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant vests over three years with 1/3 vesting on each annual anniversary of December 10, 2021, provided that Reporting Person continues to provide services to the Company through each vesting date."}],"balance_after":45000,"derivative":{"exercise_price":13.33,"expiration_date":"2028-12-09","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-21-069621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919121069621/doc4.xml","form_type":"4"}},{"id":2474026,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-12-14T19:23:31.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":10714,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSUs vest over three years with 1/3 vesting on each annual anniversary of December 10, 2021, provided that Reporting Person continues to provide services to the Company through each vesting date. The release of RSU shares will be mandatorily deferred until the Reporting Person no longer provides services to the Company."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSUs vest over three years with 1/3 vesting on each annual anniversary of December 10, 2021, provided that Reporting Person continues to provide services to the Company through each vesting date. The release of RSU shares will be mandatorily deferred until the Reporting Person no longer provides services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSUs vest over three years with 1/3 vesting on each annual anniversary of December 10, 2021, provided that Reporting Person continues to provide services to the Company through each vesting date. The release of RSU shares will be mandatorily deferred until the Reporting Person no longer provides services to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSUs vest over three years with 1/3 vesting on each annual anniversary of December 10, 2021, provided that Reporting Person continues to provide services to the Company through each vesting date. The release of RSU shares will be mandatorily deferred until the Reporting Person no longer provides services to the Company."}],"balance_after":10714,"derivative":{"underlying":"Common Stock","underlying_shares":10714},"source":{"system":"sec-edgar","filing":"0001209191-21-069621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919121069621/doc4.xml","form_type":"4"}},{"id":2764727,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2021-04-01T23:43:33.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":10196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each earned Performance Stock Unit (PSU) is settled by delivery of one share of common stock. The vesting of these PSUs was subject to the satisfaction of both performance-based and time-based vesting conditions. The performance-based condition was satisfied as to 25% of the total PSU grant upon achievement of each of four separate milestones of 20%, 30%, 40% and 50% average increases over 20 consecutive trading days of the closing price of the Issuer's common stock on the date of grant. The time-based condition will be satisfied as to 25% of the total PSU grant upon each of the first four anniversaries of the date of grant contingent upon the Reporting Person's continued service to the Issuer through each such anniversary date.  Subject to the terms of the PSU award agreement, the performance-based conditions of the PSU grant were certified as satisfied on July 2, 2020.  Therefore, vesting of these PSUs remains subject only to the time-based vesting conditions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each earned Performance Stock Unit (PSU) is settled by delivery of one share of common stock. The vesting of these PSUs was subject to the satisfaction of both performance-based and time-based vesting conditions. The performance-based condition was satisfied as to 25% of the total PSU grant upon achievement of each of four separate milestones of 20%, 30%, 40% and 50% average increases over 20 consecutive trading days of the closing price of the Issuer's common stock on the date of grant. The time-based condition will be satisfied as to 25% of the total PSU grant upon each of the first four anniversaries of the date of grant contingent upon the Reporting Person's continued service to the Issuer through each such anniversary date.  Subject to the terms of the PSU award agreement, the performance-based conditions of the PSU grant were certified as satisfied on July 2, 2020.  Therefore, vesting of these PSUs remains subject only to the time-based vesting conditions."}],"balance_after":30600,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10196},"source":{"system":"sec-edgar","filing":"0001179110-21-003974","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021003974/edgar.xml","form_type":"4"}},{"id":2764726,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-01T23:43:33.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":4059,"price":42.43,"value":172223.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 4,059 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":14018,"source":{"system":"sec-edgar","filing":"0001179110-21-003974","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021003974/edgar.xml","form_type":"4"}},{"id":2764725,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-01T23:43:33.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":10196,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18077,"source":{"system":"sec-edgar","filing":"0001179110-21-003974","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021003974/edgar.xml","form_type":"4"}},{"id":2821170,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-03T00:15:24.000Z","date":"2021-03-02","kind":"exercise","acquired":false,"shares":12166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":36496,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12166},"source":{"system":"sec-edgar","filing":"0001179110-21-002560","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021002560/edgar.xml","form_type":"4"}},{"id":2821169,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-03T00:15:24.000Z","date":"2021-03-02","kind":"tax_withholding","acquired":false,"shares":4285,"price":45.01,"value":192867.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 4,285 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":7881,"source":{"system":"sec-edgar","filing":"0001179110-21-002560","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021002560/edgar.xml","form_type":"4"}},{"id":2821168,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-03T00:15:24.000Z","date":"2021-03-02","kind":"exercise","acquired":true,"shares":12166,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12166,"source":{"system":"sec-edgar","filing":"0001179110-21-002560","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021002560/edgar.xml","form_type":"4"}},{"id":2855385,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-17T22:03:14.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":14898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."}],"balance_after":14898,"derivative":{"exercise_price":0,"exercise_date":"2022-02-15","underlying":"Common Stock","underlying_shares":14898},"source":{"system":"sec-edgar","filing":"0001179110-21-001808","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001808/edgar.xml","form_type":"4"}},{"id":2855384,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2021-02-17T22:03:14.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":25642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests one-fourth on such date and then 1/48th monthly thereafter."}],"balance_after":25642,"derivative":{"exercise_price":49.84,"exercise_date":"2022-02-15","expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":25642},"source":{"system":"sec-edgar","filing":"0001179110-21-001808","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001808/edgar.xml","form_type":"4"}},{"id":3183900,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2020-04-03T20:56:43.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":40796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting of these Performance Stock Units (PSUs) is subject to the satisfaction of both performance-based and time-based vesting conditions.  The performance-based condition will be satisfied as to 25% of the total PSU grant upon achievement of each of four separate milestones of 20%, 30%, 40% and 50% increases of the closing price of the Issuer's common stock on the date of grant.  The PSUs may be earned at any point during the three-year performance period (commencing on the date of grant) and any PSUs that are not earned during the three-year performance period will be forfeited.  The time-based condition will be satisfied as to 25% of the total PSU grant upon each of the first four anniversaries of the date of grant contingent upon the Reporting Person's continued service to the Issuer through each such anniversary date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The vesting of these Performance Stock Units (PSUs) is subject to the satisfaction of both performance-based and time-based vesting conditions.  The performance-based condition will be satisfied as to 25% of the total PSU grant upon achievement of each of four separate milestones of 20%, 30%, 40% and 50% increases of the closing price of the Issuer's common stock on the date of grant.  The PSUs may be earned at any point during the three-year performance period (commencing on the date of grant) and any PSUs that are not earned during the three-year performance period will be forfeited.  The time-based condition will be satisfied as to 25% of the total PSU grant upon each of the first four anniversaries of the date of grant contingent upon the Reporting Person's continued service to the Issuer through each such anniversary date."}],"balance_after":40796,"derivative":{"exercise_price":0,"exercise_date":"2021-04-01","underlying":"Common Stock","underlying_shares":40796},"source":{"system":"sec-edgar","filing":"0001179110-20-004645","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020004645/edgar.xml","form_type":"4"}},{"id":3228075,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-04T21:03:35.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":48662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit grant vests one-fourth on such date and then one-fourth on each anniversary thereafter."}],"balance_after":48662,"derivative":{"exercise_price":0,"exercise_date":"2021-03-02","expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":48662},"source":{"system":"sec-edgar","filing":"0001179110-20-003052","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020003052/edgar.xml","form_type":"4"}},{"id":3228074,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":36348,"kind":"person","name":"Sun Elaine D","position":1,"cik":"0001805339","reported_name":"Sun Elaine D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2020-03-04T21:03:35.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":104969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests one-fourth on such date and then 1/48th monthly thereafter."}],"balance_after":104969,"derivative":{"exercise_price":20.55,"exercise_date":"2021-03-02","expiration_date":"2030-03-02","underlying":"Common Stock","underlying_shares":104969},"source":{"system":"sec-edgar","filing":"0001179110-20-003052","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020003052/edgar.xml","form_type":"4"}}]}